Recanting of Previous Reports of Alcohol Consumption within a Large-Scale Clustered Randomised Control Trial.


Journal

Prevention science : the official journal of the Society for Prevention Research
ISSN: 1573-6695
Titre abrégé: Prev Sci
Pays: United States
ID NLM: 100894724

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 15 1 2019
medline: 19 6 2020
entrez: 15 1 2019
Statut: ppublish

Résumé

The aim of this study was to examine the extent of recanting (inconsistencies in reporting of lifetime alcohol use) and its impact on the assessment of primary outcomes within a large-scale alcohol prevention trial. One hundred and five post-primary schools in were randomised to receive either the intervention or education as normal. Participants (N = 12,738) were secondary school students in year 8/S1 (mean age 12.5) at baseline. Self-report questionnaires were administered at baseline (T0) and at T1 (+ 12 months post-baseline), T2 (+ 24 months) and T3 (+ 33 months). The primary outcomes were (i) heavy episodic drinking (consumption of ≥ 6 units in a single episode in the previous 30 days for males and ≥ 4.5 units for females) assessed at T3 and (ii) the number of alcohol-related harms experienced in the last 6 months assessed at T3. Recanting was defined as a negative report of lifetime alcohol consumption that contradicted a prior positive report. Between T1 and T3, 9.9% of students recanted earlier alcohol consumption. Recanting ranged from 4.5 to 5.3% across individual data sweeps. While recanting was significantly associated (negatively) with both primary outcomes, the difference in the rate of recanting across trial arms was small, and adjusting for recanting within the primary outcome models did not impact on the primary outcome effects. Males were observed to recant at a greater rate than females, with a borderline small-sized effect (V = .09). While differential rates of recanting have the potential to undermine the analysis of prevention trial outcomes, recanting is easy to identify and control for within trial primary outcome analyses. Adjusting for recanting should be considered as an additional sensitivity test within prevention trials.Trial Registration: ISRCTN47028486 ( http://www.isrctn.com/ISRCTN47028486 ). The date of trial registration was 23/09/2011, and school recruitment began 01/11/2011.

Identifiants

pubmed: 30637672
doi: 10.1007/s11121-019-0981-2
pii: 10.1007/s11121-019-0981-2
pmc: PMC6647483
doi:

Banques de données

ISRCTN
['ISRCTN47028486']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

844-851

Subventions

Organisme : Department of Health
ID : 10/3002/09
Pays : United Kingdom

Références

Addiction. 2007 Nov;102(11):1831-9
pubmed: 17784897
Addiction. 2009 Aug;104(8):1373-81
pubmed: 19438838
Int J Epidemiol. 2014 Aug;43(4):1272-83
pubmed: 24881045
Drug Alcohol Depend. 2000 Jul 1;60(1):19-27
pubmed: 10821986
J Consult Clin Psychol. 2002 Feb;70(1):67-78
pubmed: 11860058
J Adolesc Health. 2008 Mar;42(3):221-7
pubmed: 18295129
Public Opin Q. 2008;72(2):260-290
pubmed: 18941620
Drug Alcohol Depend. 1995 Dec;40(2):103-9
pubmed: 8745131
Addiction. 2005 Apr;100(4):562-3
pubmed: 15784073
J Addict Behav Ther Rehabil. 2014 Jan 2;3(1):1000113
pubmed: 24795898
Drug Alcohol Depend. 2011 Nov 1;118(2-3):134-40
pubmed: 21524861
Drug Alcohol Rev. 2006 Sep;25(5):413-8
pubmed: 16939935
NIDA Res Monogr. 1997;167:59-80
pubmed: 9243557
Addiction. 2005 Feb;100(2):143-4
pubmed: 15679741
Am J Epidemiol. 2009 Jun 1;169(11):1388-97
pubmed: 19363096
Drug Alcohol Depend. 2007 Jun 15;89(1):13-23
pubmed: 17196343
Addict Behav. 1997 Sep-Oct;22(5):613-23
pubmed: 9347063
J Subst Abuse. 2000;11(2):161-72
pubmed: 10989776
J Abnorm Child Psychol. 2010 Jul;38(5):645-56
pubmed: 20309624
J Stud Alcohol. 1992 Nov;53(6):636-47
pubmed: 1434637
Subst Use Misuse. 1999 Jan;34(2):269-95
pubmed: 10069753
J Subst Abuse Treat. 2008 Apr;34(3):347-55
pubmed: 17614240
Arch Suicide Res. 2016;20(2):113-41
pubmed: 26789257
Drug Alcohol Depend. 2003 Jun 5;70(3):241-53
pubmed: 12757962
BMC Med Res Methodol. 2013 Jul 16;13:92
pubmed: 23855337
J Adolesc Health. 2009 Aug;45(2):187-92
pubmed: 19628146
Addiction. 2017 Mar;112(3):477-485
pubmed: 27743424
Addiction. 2005 Feb;100(2):189-96
pubmed: 15679748
J Child Adolesc Subst Abuse. 2011 Nov 1;20(5):407-420
pubmed: 22308063
Cochrane Database Syst Rev. 2017 Sep 25;9:CD011479
pubmed: 28944453
Addiction. 1995 Jan;90(1):111-8
pubmed: 7888969
Drug Alcohol Depend. 2017 Jun 1;175:55-59
pubmed: 28391086
BMJ Open. 2018 Mar 9;8(3):e019722
pubmed: 29525770

Auteurs

Andrew Percy (A)

Centre for Evidence and Social Innovation, School of Social Sciences, Education and Social Work, Queen's University Belfast, Belfast, UK. a.percy@qub.ac.uk.

Ashley Agus (A)

Northern Ireland Clinical Trials Unit, Belfast, UK.

Jon Cole (J)

University of Liverpool, Liverpool, UK.

Paul Doherty (P)

Northern Ireland Clinical Trials Unit, Belfast, UK.

David Foxcroft (D)

Oxford Brookes University, Oxford, UK.

Séamus Harvey (S)

Bangor University, Bangor, UK.

Michael McKay (M)

University of Liverpool, Liverpool, UK.

Lynn Murphy (L)

Northern Ireland Clinical Trials Unit, Belfast, UK.

Harry Sumnall (H)

Liverpool John Moores University, Liverpool, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH